48/100BVentas stock forecast 2026–2028What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Ventas is 99.45, 11.3% above the current price of 89.39. Their targets range from 88.00 to 110.00.
Of the 13 firms that rated Ventas in the past 12 months, 10 rate it buy or strong buy, 3 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 88.00 to 110.00, with an average of 99.45.
| Buy | 10 | |
| Hold | 3 | |
| Sell | 0 |
12-month price target
| Highest target | 110.00 |
| Average target | 99.45 |
| Lowest target | 88.00 |
| Current price | 89.39 |
Ventas price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Ventas price target and rating?
How analysts rate Ventas, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
10 of 13 firms rate it buy now, against 12 of 14 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Ventas analyst upgrades, downgrades and price targets
The latest rating change came on 7 July 2026, when Barclays downgraded Ventas from Overweight to Equal Weight. Its price target is 99.00. The most recent new target came from Wells Fargo on 19 October 2026: 96.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 19 Oct 2026 | Wells Fargo John Kilichowski | Reiterated · Overweight | 104.00 → 96.00 | -7.7% | 85.86 |
| 13 Oct 2026 | Barclays | Reiterated · Equal Weight | 102.00 → 91.00 | -10.8% | 83.54 |
| 21 Sept 2026 | Evercore ISI | Reiterated · Outperform | 95.00 → 100.00 | +5.3% | 87.22 |
| 15 Sept 2026 | Jefferies Joe Dickstein | — | 100.00 → 102.00 | +2.0% | 89.10 |
| 1 Sept 2026 | Wells Fargo | Reiterated · Overweight | 88.00 → 104.00 | +18.2% | 91.18 |
| 31 Aug 2026 | Barclays | Reiterated · Equal Weight | 99.00 → 102.00 | +3.0% | 91.80 |
| 11 Aug 2026 | BMO Capital | Reiterated · Outperform | 100.00 → 107.00 | +7.0% | 91.91 |
| 31 Jul 2026 | Cantor Fitzgerald Richard Anderson | Reiterated · Overweight | 93.00 → 102.00 | +9.7% | 92.15 |
| 22 Jul 2026 | Mizuho Securities | Reiterated · Outperform | 98.00 → 104.00 | +6.1% | 97.62 |
| 7 Jul 2026 | Barclays Richard Hightower | Downgraded · Overweight → Equal Weight | 99.00 | — | 92.21 |
| 18 Jun 2026 | Scotiabank Nicholas Yulico | Reiterated · Sector Perform | 95.00 → 88.00 | -7.4% | 81.18 |
| 16 Jun 2026 | Raymond James | — | 78.00 → 94.00 | +20.5% | 83.89 |
| 16 Jun 2026 | Deutsche Bank Omotayo Okusanya | — | 100.00 | — | 83.46 |
| 22 May 2026 | Mizuho Securities Vikram Malhotra | — | 98.00 | — | 88.00 |
| 21 May 2026 | Scotiabank Nicholas Yulico | Reiterated · Sector Perform | 74.00 → 95.00 | +28.4% | 88.28 |
| 19 May 2026 | Goldman Sachs | — | 100.00 → 110.00 | +10.0% | 88.14 |
| 12 May 2026 | Jefferies | — | 93.00 → 100.00 | +7.5% | 88.53 |
| 7 May 2026 | KeyBanc | Reiterated · Overweight | 85.00 → 95.00 | +11.8% | 85.34 |
| 4 May 2026 | BMO Capital Juan Sanabria | — | 100.00 | — | 88.04 |
| 4 May 2026 | RBC Capital | Reiterated · Outperform | 91.00 → 98.00 | +7.7% | 88.02 |
| 4 May 2026 | UBS | Reiterated · Neutral | 85.00 → 93.00 | +9.4% | 88.02 |
| 29 Apr 2026 | Evercore ISI | Reiterated · Outperform | 95.00 | — | 87.25 |
| 13 Feb 2026 | Morgan Stanley | — | 90.00 | — | 85.25 |
| 10 Feb 2026 | Argus Research | — | 75.00 → 88.00 | +17.3% | 83.39 |
| 10 Feb 2026 | RBC Capital | Reiterated · Outperform | 91.00 | — | 82.79 |
| 9 Feb 2026 | Goldman Sachs Julien Blouin | — | 94.00 → 100.00 | +6.4% | 82.75 |
| 9 Feb 2026 | UBS Michael Goldsmith | — | 73.00 → 85.00 | +16.4% | 83.12 |
| 9 Jan 2026 | Goldman Sachs | — | 94.00 | — | 75.08 |
| 5 Jan 2026 | Cantor Fitzgerald | — | 85.00 → 93.00 | +9.4% | 75.40 |
| 15 Dec 2025 | Jefferies | — | 93.00 | — | 78.70 |
| 4 Dec 2025 | KeyBanc Austin Wurschmidt | Reiterated · Overweight | 85.00 | — | 80.00 |
| 25 Nov 2025 | Wells Fargo | Reiterated · Overweight | 80.00 → 88.00 | +10.0% | 79.76 |
Ventas EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Ventas beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 46.7% off the result, either way, and their revenue estimate 2.7%, over the last 12 quarters.
- EPS beats
- 47 / 96
- Revenue beats
- 60 / 96
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +6.5%
- Since
- April 2003
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 27 Oct 2026 | 0.16 | 0.13 | -19.8% | 1.77B | 1.83B | +3.6% |
| Q2 FY2026 | 29 Jul 2026 | 0.14 | 0.14 | -1.6% | 1.68B | 1.73B | +2.9% |
| Q1 FY2026 | 27 Apr 2026 | 0.12 | 0.11 | -10.5% | 1.59B | 1.66B | +4.5% |
| Q4 FY2025 | 5 Feb 2026 | 0.10 | 0.15 | +49.0% | 1.50B | 1.57B | +4.1% |
| Q3 FY2025 | 29 Oct 2025 | 0.09 | 0.14 | +52.2% | 1.44B | 1.49B | +3.6% |
| Q2 FY2025 | 30 Jul 2025 | 0.85 | 0.15 | -82.4% | 1.38B | 1.42B | +3.1% |
| Q1 FY2025 | 30 Apr 2025 | 0.82 | 0.11 | -86.6% | 1.32B | 1.36B | +3.2% |
| Q4 FY2024 | 12 Feb 2025 | 0.06 | 0.13 | +105.3% | 1.26B | 1.29B | +2.4% |
| Q3 FY2024 | 30 Oct 2024 | 0.80 | 0.80 | 0.0% | 1.23B | 1.24B | +0.4% |
| Q2 FY2024 | 1 Aug 2024 | 0.04 | 0.05 | +25.0% | 1.19B | 1.20B | +0.7% |
| Q1 FY2024 | 2 May 2024 | -0.33 | -0.04 | +87.7% | 1.16B | 1.20B | +3.1% |
| Q4 FY2023 | 14 Feb 2024 | -0.16 | -0.23 | -40.0% | 1.15B | 1.16B | +1.4% |
Ventas stock price 2026–2028: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
There are no price scenarios for Ventas: its P/E has been above 60, or from losses, too often in the last five years to price its earnings at, and similar companies' P/Es put its value too far from its price to stand in. The earnings analysts expect are in the estimates above.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.